InvestorsHub Logo
Followers 0
Posts 131
Boards Moderated 0
Alias Born 12/13/2016

Re: None

Tuesday, 12/13/2016 6:14:28 PM

Tuesday, December 13, 2016 6:14:28 PM

Post# of 233067
Ok, I have been long CYDY for three years. I have a large position with an average price of about .95. Remember the Chairman of CYDY is a former senior VP of Global Sales at Gild.
Do not think for a moment he has not on top of this. I believe we have resubmitted for orphan drug status and breakthrough designation. Both have a timeline, and I think we are close. Can you imagine the FDA asking for 300, and drops to 150, and then 30? It sounds like we are not only their best friend but a partner. Nadar said his goal was to sell the Company but have a line of credit left of 90 million if we need to go to developing and selling the drug. We still have 12 positions in phase 2 for many things, stopping cancer from metastasizing "breast, prostate, lupus, bone marrow. Remember the person who had lupus and was in the phase 2 trial and came out with no signs of that disease in his body. I think we will license pro140 to someone for whatever price and work on developing the other 12 in phase 2. I cannot believe we will just give away what is in phase 2. My prediction on a small side is over a 100 a share. After all is said and done.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News